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Introduction:  
In vivo 1H MRS allows non invasive characterization of brain metabolism and it has been used for studying brain metabolic changes in a wide range 
of neurodegenerative diseases. The prion diseases form a group of fatal neurodegenerative diseases, also described as transmissible spongiform 
encephalopathies (TSEs), which are caused by abnormal conformational isomers (PrPSc) of the host-encoded prion proteins (PrPc) (1). Both, the 
physiological function of PrPc and the molecular pathways leading to neurodegeneration in prion disease remain unknown. Consequently, different 
transgenic mouse models of prion disease were created to study the role of the PrPc. These models were crucial in elucidating precursor-product 
relationship between PrPc and PrPSc. Among these models, the mice lacking prion protein (Prnp -/-) developed normally and no severe pathologies 
were observed (2). In contrast, mice expressing PrP which lacks defined domains (PrPΔ32-121) suffer from ataxia, astrogliosis and cerebellar granule 
cell loss (3). These findings accentuate the need for a non-invasive and longitudinal investigation technique which could bring additional 
information. From our knowledge, no in vivo MRS study was performed in transgenic mouse models of prion disease. Therefore, we performed an 
in vivo longitudinal 1H MRS study at 14.1T with the aim to measure the neurochemical profile of Prnp -/- and PrPΔ32-121 mice in the hippocampus 
and cerebellum, respectively.  
Methods: 
Mice lacking prion protein (Prnp -/- mice) and mice expressing PrP which lacks defined domains (PrPΔ32-121) were created as described in ref (2) and 
(3), respectively.1H spectra were measured at 6 and 12 months of age on 18 mice (6 Prnp-/-, 6 PrPΔ32-121 and 6 wild type (WT)). Anesthesia was 
maintained at 1.3 ± 0.2 % of isoflurane in oxygen, body temperature was kept at 36.5 ± 0.2 °C. All data were acquired on a 14.1T/26cm system 
(Varian/Magnex Scientific) using a home-built 14mm x 21mm quadrature coil as RF transceiver and an ultra-short-echo time SPECIAL 
spectroscopy sequence (TE=2.8ms, TR=4s, 400 scans) (4). The static field was shimmed by FASTMAP. A VOI of 1.3×2×2.2mm3 was selected in 
the hippocampus and a second VOI of 2x2.5x2mm3 was selected in the cerebellum. After first and second order shimming, the typical linewidth of 
water resonance at TE=2.8 ms was 18-23 Hz. Metabolite concentrations were estimated using LCModel (5), combined with a simulated basis-set of 
metabolites and the spectrum of macromolecules measured in vivo. Absolute metabolite concentrations were obtained using unsuppressed water 
signal as a reference. 
Results and Discussion: 
No difference in theT2 weighted image appearance was observed between the 
WT and Prnp -/- or PrPΔ32-121 animals. In general, spectra exhibited excellent 
signal-to-noise ratio and notable differences in metabolite signals were 
discernable (Fig. 1). 
The neurochemical profile (mean ± SEM) measured at 12 months in the 
hippocampus and cerebellum of Prnp -/, WT and PrPΔ32-121 mice is shown in 
Fig. 2. For the Prnp -/- mice at 6 months the overall neurochemical profile was 
similar to the WT in the hippocampus and cerebellum (data not shown). 
However, at 12 months a significant increase of Glu (30%), Ins (20%) and Lac 
(100%) was noticed in the hippocampus. A significant increase of Lac (100%) 
was also observed in the cerebellum. The PrPΔ32-121 mice showed no significant 
changes in the hippocampus at 6 months; however a significant increase of Ins 
(15%) and Glu (20%) was found in the cerebellum (data not shown). At 12 
months we observed a significant decrease of tNAA (20%) in both 
hippocampus and cerebellum. The significant increase in Ins noticed in the 
cerebellum at 6 months was also observed at 12 months (17%). 
We evaluated for the first time the in vivo concentration of 19 metabolites at 6 and 12 months in the hippocampus and cerebellum of Prnp -/- and 
PrPΔ32-121 mice, respectively. In contrast to histology and behavioral tests (2) where no significant changes were observed, our data showed 
significant changes in the brain metabolism of Prnp -/- mice. The increase of Glu, Lac and Ins in the hippocampus at 12 months seems to indicate a 
dysfunction in the neurotransmitter metabolism and astrogliosis.  
The decrease of tNAA detected in PrPΔ32-121 mice in 
both hippocampus and cerebellum at 12 months 
seems to reflect neuronal loss in agreement with the 
histological findings (3). In addition, the increase of 
Ins in the cerebellum at 6 and 12 months may reflect 
astrogliosis related to an inflammatory process, 
consistent with the histological features (3). 
In conclusion, high-field MR spectroscopy is 
capable of detecting changes in brain metabolism of 
Prnp-/- and PrPΔ32-121 mice compared with the WT 
animals and consequently provides additional 
information. 
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Fig. 2: Neurochemical profile (mean ± SEM) in the hippocampus (H) and cerebellum © of Prnp -
/, WT and PrPΔ32-121 mice at 12 months old. **<0.005, *<0.03 
Fig. 1: SPECIAL 1H spectra acquired at 12 months old in the 
hippocampus and cerebellum of a WT and PrPΔ32-121 mouse. 
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